[EN] TREATMENT OF PAIN BY TARGETING NR4A1<br/>[FR] TRAITEMENT DE LA DOULEUR PAR CIBLAGE DE NR4A1
申请人:UNIV CINCINNATI
公开号:WO2021042038A1
公开(公告)日:2021-03-04
The present invention involves a method of treating pain. The method treats a patient having post-operative pain or chemotherapy induced neuropathic pain, and it involves a) assessing the patient to determine if they are experiencing post-operative pain or chemotherapy induced neuropathic pain, and if such pain is diagnosed; b) administering to the patient a therapeutically effective amount of an agonist for the nuclear receptor subfamily 4, group A, member 1 (NR4A1). In one embodiment, the agonist is selected from the group consisting of Cytosporone B, Ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)-phenyl] acetate (TMPA), 1,3,7-trihydroxy-2,4-diprenylxanthone (CCE9), 1-(3,4,5-trihydroxyphenyl)-nonan-1-one (THPN), DIM-C-pPhOCH3 (C-DIM-5), 1,1-bis(3 '-indolyl)-1-(phenyl)methane (DIM-C-Ph) and 1,1-bis(3 '-indolyl)-1-(p-anisyl)methane (DIM-C-pPhOCH3).